CAFs exposed to neoadjuvant chemotherapy secrete chemokines like Glu-Leu-Arg (ELR) motif-positive chemokines, enhancing breast cancer cell invasion through CXCR2. The gene discussed is CXCR2; the disease is breast cancer.